Research ArticleArticle
Therapeutic Strategy Combining Intravenous Cyclophosphamide Followed by Oral Azathioprine to Treat Worsening Interstitial Lung Disease Associated with Systemic Sclerosis: A Retrospective Multicenter Open-label Study
ALICE BÉREZNÉ, BRIGITTE RANQUE, DOMINIQUE VALEYRE, MICHEL BRAUNER, YANNICK ALLANORE, DAVID LAUNAY, VÉRONIQUE LE GUERN, JEAN-EMMANUEL KAHN, LOUIS-JEAN COUDERC, JOËL CONSTANS, PASCAL COHEN, ALFRED MAHR, CHRISTIAN PAGNOUX, ERIC HACHULLA, ANDRÉ KAHAN, JEAN CABANE, LOÏC GUILLEVIN and LUC MOUTHON
The Journal of Rheumatology June 2008, 35 (6) 1064-1072;
ALICE BÉREZNÉ
BRIGITTE RANQUE
DOMINIQUE VALEYRE
MICHEL BRAUNER
YANNICK ALLANORE
DAVID LAUNAY
VÉRONIQUE LE GUERN
JEAN-EMMANUEL KAHN
LOUIS-JEAN COUDERC
JOËL CONSTANS
PASCAL COHEN
ALFRED MAHR
CHRISTIAN PAGNOUX
ERIC HACHULLA
ANDRÉ KAHAN
JEAN CABANE
LOÏC GUILLEVIN
LUC MOUTHON
In this issue
Therapeutic Strategy Combining Intravenous Cyclophosphamide Followed by Oral Azathioprine to Treat Worsening Interstitial Lung Disease Associated with Systemic Sclerosis: A Retrospective Multicenter Open-label Study
ALICE BÉREZNÉ, BRIGITTE RANQUE, DOMINIQUE VALEYRE, MICHEL BRAUNER, YANNICK ALLANORE, DAVID LAUNAY, VÉRONIQUE LE GUERN, JEAN-EMMANUEL KAHN, LOUIS-JEAN COUDERC, JOËL CONSTANS, PASCAL COHEN, ALFRED MAHR, CHRISTIAN PAGNOUX, ERIC HACHULLA, ANDRÉ KAHAN, JEAN CABANE, LOÏC GUILLEVIN, LUC MOUTHON
The Journal of Rheumatology Jun 2008, 35 (6) 1064-1072;
Therapeutic Strategy Combining Intravenous Cyclophosphamide Followed by Oral Azathioprine to Treat Worsening Interstitial Lung Disease Associated with Systemic Sclerosis: A Retrospective Multicenter Open-label Study
ALICE BÉREZNÉ, BRIGITTE RANQUE, DOMINIQUE VALEYRE, MICHEL BRAUNER, YANNICK ALLANORE, DAVID LAUNAY, VÉRONIQUE LE GUERN, JEAN-EMMANUEL KAHN, LOUIS-JEAN COUDERC, JOËL CONSTANS, PASCAL COHEN, ALFRED MAHR, CHRISTIAN PAGNOUX, ERIC HACHULLA, ANDRÉ KAHAN, JEAN CABANE, LOÏC GUILLEVIN, LUC MOUTHON
The Journal of Rheumatology Jun 2008, 35 (6) 1064-1072;